Rallybio and Candid Therapeutics announce merger agreement Mar 2, 2026 08:01AM
Rallybio Corporation and Candid Therapeutics Announce Merger Agreement Mar 2, 2026 08:00AM
Rallybio to Present at the TD Cowen 45th Annual Health Care Conference Feb 25, 2025 08:00AM
Rallybio to Present at the TD Cowen 44th Annual Health Care Conference Feb 26, 2024 08:00AM
Rallybio to Present at Upcoming Investor Conferences in March Mar 1, 2023 08:00AM


Jan 31, 2023 04:08PM Rallybio Corporation (RLYB) Appoints Jonathan I. Lieber as CFO
Jan 31, 2023 04:05PM Rallybio Announces Appointment of Jonathan I. Lieber as Chief Financial Officer
Jan 5, 2023 08:00AM Rallybio Highlights Portfolio Advances and Outlines Expected Milestones in 2023
Nov 11, 2022 05:23AM Rallybio Corporation (RLYB) Prices $50M Public Offering at $6/sh
Nov 10, 2022 11:51PM Rallybio Announces Pricing of $50 Million Public Offering
Nov 10, 2022 09:15AM Rallybio Corporation (RLYB) Announces $75M Proposed Public Offering
Nov 10, 2022 09:15AM Rallybio Announces Proposed Public Offering
Feb 28, 2022 08:00AM Rallybio to Present at the Cowen 42nd Annual Health Care Conference
Aug 23, 2021 05:35AM UPDATE: Cowen Starts Rallybio Corp. (RLYB) at Outperform
Aug 2, 2021 04:05PM Rallybio Corporation Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Jul 29, 2021 05:46AM Rallybio Corporation (RLYB) Prices 6.2M Share IPO at $13/sh
Jul 28, 2021 09:10PM Rallybio Corporation Announces Pricing of Initial Public Offering
Jul 2, 2021 04:37PM Rallybio Corporation (RLYB) Files up to $100M IPO